Eyantra Ventures reported a net loss of Rs 3.75 crore for Q1 FY27, widening from the Rs 3.43 crore loss recorded in the same period last year. Revenue from operations dipped slightly to Rs 19.17 crore. The company is currently undergoing significant structural changes, including the NCLT-approved merger of its subsidiary, Prismberry Technologies, and the decision to strike off its UAE-based unit, eYantra Ventures FZE.
Eyantra Ventures Reports Q1 FY27 Results Amid Structural Overhaul
Net Loss: Rs 3.75 Crore
Revenue from Operations: Rs 19.17 Crore
Reader Takeaway: Revenue decline and widening losses highlight operational pressure, though ongoing subsidiary restructuring may streamline future business activities.
What just happened
Eyantra Ventures Limited announced its financial results for the first quarter of fiscal year 2027, ending June 30, 2026. The company reported a net loss of Rs 3.75 crore, reflecting a year-on-year increase in losses compared to the Rs 3.43 crore deficit in Q1 FY26. Revenue from operations declined to Rs 19.17 crore from Rs 19.56 crore in the year-ago period.
Why this matters
The financial results underscore continued pressure on the company's core operations. While merchandise sales saw a moderate uptick to Rs 12.36 crore, the decline in hospital services and pharmacy product revenue dragged down the total performance. Investors are watching to see if the recent corporate restructuring can improve future margins.
Corporate Updates
The Board of Directors confirmed a decision on July 2, 2026, to close its non-operational wholly-owned subsidiary in the UAE, eYantra Ventures FZE. Additionally, the NCLT Hyderabad approved the merger of Prismberry Technologies Private Limited on July 15, 2026, with an appointed date of April 1, 2026. A new US-based subsidiary, EYANTRA VENTURES INC, was incorporated in May 2025, though it remains inactive.
Risks to watch
The primary concern remains the company's inability to turn a profit. The widening net loss indicates significant operational challenges that need to be addressed. Furthermore, while the NCLT has approved the Prismberry Technologies merger, the actual amalgamation process is still in its intermediate stages, leaving potential execution risks on the table.
What to track next
Shareholders should monitor the integration of Prismberry Technologies and the eventual closure of the UAE subsidiary. These moves are intended to streamline the group’s footprint, and evidence of cost savings or improved revenue quality from the remaining business segments will be critical for a recovery in share price performance.